BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28727165)

  • 1. Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome-Substudy of randomized trial between diet, exercise and diet plus exercise for weight control.
    Nybacka Å; Hellström PM; Hirschberg AL
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):680-688. PubMed ID: 28727165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G; Davidson CR; Billings DL
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
    PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS).
    Szczuko M; Skowronek M; Zapałowska-Chwyć M; Starczewski A
    Rocz Panstw Zakl Hig; 2016; 67(4):419-426. PubMed ID: 27925712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.
    Soares NP; Santos AC; Costa EC; Azevedo GD; Damasceno DC; Fayh AP; Lemos TM
    Ann Nutr Metab; 2016; 68(3):220-7. PubMed ID: 27073909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
    Roessler KK; Birkebaek C; Ravn P; Andersen MS; Glintborg D
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):272-7. PubMed ID: 23237575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.